Micro-Navigation:

News

Fresenius Medical Care announces presentation of first results from the CALMAG study for phosphate binder OsvaRen®

29. Oct 2009 |  more

Events

World Congress of Nephrology 2009 - Renal Pharma Scientific Symposium: Presentations available now

01. Jul 2009  | more

Macro-Navigation:

Imprint

Published by
Fresenius Medical Care Deutschland GmbH,
which is represented by its Managing Directors: Roberto Fusté, Dr. Emanuele Gatti, Rolf Groos, Dr. Angelo Mößlang, Eberhard Sieger, Norbert Weber

Edited by
Fresenius Medical Care Deutschland GmbH
Renal Pharma
Else-Kröner-Straße 1
61352 Bad Homburg
Germany

Tel.:++49 6172 609 0
Fax:++49 6172 609 5638
Email: renalpharma@fmc-ag.com

District Court: Bad Homburg, HRB 5748
Identification number for turnover tax: DE 812033564